This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
public health | 193 |
united states | 167 |
infectious diseases | 140 |
infectious disease | 117 |
tax evasion | 99 |
base location | 89 |
biological weapons | 88 |
threat agents | 85 |
bioterrorism agents | 81 |
health care | 80 |
risk perception | 79 |
biological agents | 77 |
small intestine | 75 |
agent i | 75 |
inhalational anthrax | 73 |
based modeling | 72 |
infectious agents | 69 |
channel effects | 69 |
biological warfare | 68 |
bacillus anthracis | 65 |
incubation period | 65 |
may also | 63 |
laboratory animals | 61 |
snow agent | 60 |
social distancing | 60 |
infectious agent | 57 |
salivary glands | 56 |
naturally occurring | 54 |
based model | 54 |
agent system | 53 |
infected agents | 53 |
ebola virus | 53 |
cord uid | 52 |
doc id | 52 |
call center | 51 |
biological threat | 49 |
based models | 49 |
homeland security | 48 |
epithelial cells | 48 |
social distance | 48 |
antimicrobial agents | 47 |
disease surveillance | 47 |
nucleic acid | 45 |
syndromic surveillance | 43 |
acute respiratory | 43 |
gastric mucosa | 42 |
pneumonic plague | 41 |
disease control | 41 |
sir model | 40 |
hiv aids | 39 |
social interactions | 39 |
care workers | 39 |
infection rate | 39 |
critical care | 38 |
respiratory syndrome | 38 |
intestinal metaplasia | 38 |
rats treated | 38 |
chemical weapons | 38 |
emerging infectious | 37 |
biological attack | 37 |
lamina propria | 37 |
health zone | 37 |
nerve agent | 37 |
botulinum toxin | 36 |
growth factor | 36 |
audit intensity | 36 |
gastrointestinal tract | 35 |
spongiform encephalopathy | 35 |
household agents | 35 |
states department | 35 |
total number | 35 |
spongiform encephalopathies | 34 |
nerve agents | 34 |
antimicrobial concrete | 34 |
plasmonic sensors | 34 |
marginal infections | 34 |
viral shedding | 33 |
averse agent | 33 |
risky asset | 33 |
viral hemorrhagic | 33 |
agent will | 32 |
chemical threat | 32 |
salivary gland | 32 |
warfare agents | 32 |
small intestinal | 32 |
disease outbreaks | 32 |
yersinia pestis | 32 |
agent based | 32 |
new york | 31 |
risk analysis | 31 |
mission controller | 31 |
independent agents | 30 |
biological weapon | 30 |
high school | 30 |
healthcare workers | 30 |
primarily persuasive | 30 |
exclusive agents | 30 |
primarily informative | 30 |
chemical agents | 30 |
risk assessment | 30 |
marketing efforts | 30 |
hemorrhagic fever | 30 |
social networks | 30 |
surveillance system | 30 |
severe acute | 30 |
high risk | 30 |
chemical warfare | 29 |
biological agent | 29 |
large number | 29 |
epidermal growth | 29 |
plasmonic sensor | 28 |
transmission rate | 28 |
infected agent | 28 |
exclusive agent | 28 |
agents may | 28 |
west nile | 27 |
tax audits | 27 |
active shooter | 27 |
goblet cells | 27 |
surface plasmon | 27 |
sulfur mustard | 27 |
decision making | 27 |
medical countermeasures | 27 |
intestinal mucosa | 27 |
epidemic model | 27 |
exhaust air | 27 |
immune response | 26 |
world war | 26 |
shopping outcomes | 26 |
acid secretion | 26 |
synthetic biology | 26 |
hemorrhagic fevers | 25 |
scrapie agent | 25 |
activity levels | 25 |
optimization problems | 25 |
surveillance systems | 25 |
world health | 25 |
dynamic optimization | 25 |
postexposure prophylaxis | 25 |
mass casualty | 25 |
francisella tularensis | 24 |
provincial health | 24 |
risk management | 24 |
lymph nodes | 24 |
informative channel | 24 |
pediatric patients | 24 |
human primates | 24 |
mass destruction | 24 |
began shooting | 24 |
made available | 24 |
unit clerks | 23 |
health organization | 23 |
intelligent adversary | 23 |
law enforcement | 23 |
inflammatory drugs | 23 |
biological threats | 23 |
electron microscopy | 23 |
activity level | 23 |
bovine spongiform | 23 |
large numbers | 23 |
nervous system | 23 |
cell proliferation | 23 |
plasmon resonance | 22 |
may lead | 22 |
risk aversion | 22 |
audit memory | 22 |
rapid detection | 22 |
independent agent | 22 |
mg kg | 22 |
cutaneous anthrax | 22 |
immune system | 22 |
butylated hydroxyanisole | 22 |
therapeutic agents | 22 |
dengue virus | 22 |
social network | 22 |
coping appraisal | 22 |
data set | 22 |
wide range | 21 |
bioterrorism event | 21 |
paneth cells | 21 |
health division | 21 |
even though | 21 |
supportive care | 21 |
nash equilibrium | 21 |
central nervous | 21 |
zone executive | 21 |
international license | 21 |
oral cavity | 21 |
mission specification | 21 |
population density | 21 |
viral agents | 21 |
clinical presentation | 21 |
active cases | 21 |
protective equipment | 21 |
author funder | 20 |
copyright holder | 20 |
objective function | 20 |
healthy agents | 20 |
granted medrxiv | 20 |
executive team | 20 |
york city | 20 |
ehr system | 20 |
endemic prevalence | 20 |
control measures | 20 |
parietal cells | 20 |
receptor antagonist | 20 |
absorptive cells | 20 |
glandular mucosa | 20 |
epidemic size | 20 |
jumping outside | 20 |
phase transitions | 20 |
individual agents | 20 |
real world | 20 |
polymerase chain | 19 |
accidental release | 19 |
viral gastroenteritis | 19 |
soviet union | 19 |
biological systems | 19 |
two types | 19 |
post office | 19 |
respiratory distress | 19 |
decision makers | 19 |
bioterrorist attack | 19 |
posted july | 19 |
early detection | 19 |
random variable | 19 |
resource allocation | 19 |
health management | 19 |
high doses | 19 |
gastric cancer | 19 |
wage rate | 19 |
respiratory failure | 19 |
version posted | 19 |
sis model | 18 |
economic systems | 18 |
simulation model | 18 |
personal protective | 18 |
gastric acid | 18 |
anthrax attacks | 18 |
differential diagnoses | 18 |
social interaction | 18 |
small bowel | 18 |
gastric glands | 18 |
side effects | 18 |
causative agent | 18 |
disease transmission | 18 |
model parameters | 18 |
toxicity studies | 18 |
respiratory tract | 18 |
converting phosphor | 18 |
periphery structure | 17 |
gp clinics | 17 |
nile virus | 17 |
agents will | 17 |
social structure | 17 |
real time | 17 |
chain reaction | 17 |
mortality rates | 17 |
squamous epithelium | 17 |
gold nanoparticles | 17 |
coronavirus disease | 17 |
staff physicians | 17 |
medical response | 17 |
low risk | 17 |
steroidal anti | 17 |
agents include | 17 |
drug delivery | 17 |
average number | 17 |
clinical syndromes | 17 |
delivery systems | 17 |
persuasive channel | 17 |
mitotic activity | 17 |
different types | 16 |
gastric glandular | 16 |
avian influenza | 16 |
soiled bedding | 16 |
susceptible host | 16 |
smallpox virus | 16 |
bt attack | 16 |
influenza virus | 16 |
colonic mucosa | 16 |
inflammatory cells | 16 |
density function | 16 |
animal models | 16 |
economic impact | 16 |
time step | 16 |
infections generated | 16 |
clinical trials | 16 |
monoclonal antibodies | 16 |
become infected | 16 |
representative agent | 16 |
spontaneous outbreak | 16 |
worker groups | 16 |
infected individuals | 16 |
bio watch | 16 |
disease agents | 15 |
new disease | 15 |
primary influence | 15 |
west africa | 15 |
critically ill | 15 |
transfusion transmission | 15 |
escherichia coli | 15 |
isolator cages | 15 |
infected individual | 15 |
enterochromaffin cells | 15 |
large intestine | 15 |
contact tracing | 15 |
mast cells | 15 |
infection control | 15 |
antiviral agents | 15 |
cellular automata | 15 |
bioterrorism preparedness | 15 |
ivc systems | 15 |
also occur | 15 |
lymphoid tissue | 15 |
random variables | 15 |
herd immunity | 15 |
natural disasters | 15 |
submandibular gland | 15 |
agent daemon | 15 |
agent approach | 15 |
suspicious cases | 15 |
central locations | 15 |
agent channel | 15 |
anthrax vaccine | 15 |
ehr systems | 15 |
will likely | 14 |
based sensor | 14 |
infected cases | 14 |
static isolator | 14 |
urban environments | 14 |
epidemic spreading | 14 |
processing time | 14 |
may become | 14 |
variola major | 14 |
case study | 14 |
decision analysis | 14 |
asset price | 14 |
target analyte | 14 |
time series | 14 |
highly infectious | 14 |
anthrax spores | 14 |
bt event | 14 |
agent systems | 14 |
health center | 14 |
may occur | 14 |
time pcr | 14 |
time period | 14 |
health data | 14 |
virus infection | 14 |
detection methods | 14 |
based approaches | 14 |
memory property | 14 |
highest priority | 14 |
smallpox vaccine | 14 |
health authorities | 14 |
based modelling | 14 |
characterised histologically | 14 |
droplet precautions | 14 |
mucous cells | 14 |
ivc system | 14 |
bone marrow | 14 |
sir epidemic | 14 |
alcian blue | 14 |
distress syndrome | 14 |
antibiotic therapy | 14 |
clinical disease | 14 |
important role | 14 |
optimal consumption | 14 |
hospital worker | 13 |
coxiella burnetii | 13 |
financial markets | 13 |
lateral flow | 13 |
recovered agents | 13 |
rats fed | 13 |
widely used | 13 |
persuasive channels | 13 |
molecular weight | 13 |
agents assigned | 13 |
clinical illness | 13 |
average degree | 13 |
public goods | 13 |
ill patients | 13 |
shooter incidents | 13 |
agents move | 13 |
future research | 13 |
inflammatory response | 13 |
short time | 13 |
antimicrobial effect | 13 |
potential biological | 13 |
mission agent | 13 |
diseases caused | 13 |
intentional release | 13 |
monoclonal antibody | 13 |
tax audit | 13 |
distribution channels | 13 |
optimization problem | 13 |
small number | 13 |
war i | 13 |
every agent | 13 |
lessons learned | 13 |
chief cells | 13 |
average infections | 13 |
following administration | 13 |
make decisions | 13 |
program control | 13 |
cell hyperplasia | 13 |
one another | 13 |
biological attacks | 13 |
aids epidemic | 13 |
also reported | 13 |
rna viruses | 13 |
human services | 13 |
may produce | 13 |
middle east | 13 |
medical aspects | 13 |
infected animals | 13 |
detection system | 13 |
bubonic plague | 13 |
septicemic plague | 13 |
brain injury | 13 |
health system | 13 |
closest location | 13 |
patients will | 12 |
randomly chosen | 12 |
direct contact | 12 |
fatality rate | 12 |
plasma cells | 12 |
examples include | 12 |
endocrine cells | 12 |
balanced channel | 12 |
will also | 12 |
primary blast | 12 |
protein synthesis | 12 |
equine encephalitis | 12 |
phosphor technology | 12 |
adverse effects | 12 |
glandular stomach | 12 |
medical management | 12 |
clinical manifestations | 12 |
fever virus | 12 |
dengue viruses | 12 |
mortality rate | 12 |
normally distributed | 12 |
patient contacts | 12 |
increased il | 12 |
terrorist attacks | 12 |
emerging disease | 12 |
parameter values | 12 |
guinea pigs | 12 |
per cent | 12 |
human transmission | 12 |
muscularis mucosa | 12 |
large scale | 12 |
clinical features | 12 |
carbon nanotubes | 12 |
high level | 12 |
high sensitivity | 12 |
social science | 12 |
utility agent | 12 |
phase transition | 12 |
flow assay | 12 |
based simulation | 12 |
histological features | 12 |
wide variety | 12 |
public policy | 12 |
may result | 12 |
may develop | 12 |
group members | 12 |
epidemic processes | 12 |
fl uenza | 12 |
similar changes | 12 |
peripheral locations | 12 |
novel coronavirus | 12 |
bt agents | 12 |
war ii | 12 |
dawley rats | 12 |
antimicrobial property | 12 |
virus disease | 12 |
influenza pandemic | 12 |
electron microscopic | 12 |
mission agents | 12 |
human behavior | 12 |
may vary | 12 |
terrorist groups | 12 |
vibrio cholerae | 12 |
human subjects | 12 |
mechanical ventilation | 12 |
squamous carcinomas | 12 |
mathematical models | 12 |
natural outbreak | 12 |
fischer rats | 12 |
disease spread | 12 |
water supplies | 12 |
blast injury | 12 |
peer review | 11 |
diagnostic techniques | 11 |
group learning | 11 |
large quantities | 11 |
sodium tungstate | 11 |
salivary tissue | 11 |
mice housed | 11 |
cell populations | 11 |
inflammatory agents | 11 |
susceptible population | 11 |
event tree | 11 |
emergency medical | 11 |
south korea | 11 |
human populations | 11 |
squamous metaplasia | 11 |
chest radiograph | 11 |
social behavior | 11 |
intelligent adversaries | 11 |
defender decision | 11 |
blood safety | 11 |
transmission rates | 11 |
based approach | 11 |
detection method | 11 |
epithelial cell | 11 |
infected person | 11 |
yellow fever | 11 |
structural collapse | 11 |
avian flu | 11 |
also produce | 11 |
epithelial hyperplasia | 11 |
disease may | 11 |
early stages | 11 |
among agents | 11 |
optimal solution | 11 |
syndrome coronavirus | 11 |
organic antimicrobial | 11 |
compressive strength | 11 |
channel elasticities | 11 |
experimental animals | 11 |
reinforcement learning | 11 |
iron oxide | 11 |
mobile phone | 11 |
von neumann | 11 |
clinical practice | 11 |
pleural effusions | 11 |
closely related | 11 |
collective learning | 11 |
one agent | 11 |
septic shock | 11 |
primary pneumonic | 11 |
shedding rate | 11 |
highly sensitive | 11 |
parietal cell | 11 |
adversary risk | 11 |
risk communication | 11 |
connective tissue | 11 |
cost functions | 11 |
diffusion process | 11 |
time spent | 11 |
response time | 11 |
infected patients | 11 |
weapons convention | 11 |
helicobacter pylori | 11 |
brush border | 11 |
many people | 11 |
rats following | 11 |
health centers | 11 |
person transmission | 11 |
confirmed cases | 11 |
host cell | 10 |
cause disease | 10 |
health facilities | 10 |
clinical signs | 10 |
global social | 10 |
agent enters | 10 |
surface epithelium | 10 |
receptor antagonists | 10 |
zinc oxide | 10 |
acinar cells | 10 |
central areas | 10 |
large systems | 10 |
blood donors | 10 |
neutral mucins | 10 |
secondary infections | 10 |
committed suicide | 10 |
receptor agonists | 10 |
susceptible agents | 10 |
radiation syndrome | 10 |
single case | 10 |
microbiology laboratory | 10 |
per vaccination | 10 |
quantum dots | 10 |
see table | 10 |
steady state | 10 |
high morbidity | 10 |
molecularly imprinted | 10 |
military personnel | 10 |
modeling approach | 10 |
inhalation anthrax | 10 |
bactericidal effect | 10 |
concrete structures | 10 |
web channel | 10 |
infection rates | 10 |
chemical toxicity | 10 |
east respiratory | 10 |
viral load | 10 |
epidemic threshold | 10 |
infected people | 10 |
much higher | 10 |
oxide nanoparticles | 10 |
body fluids | 10 |
results suggest | 10 |
three types | 10 |
commonly used | 10 |
us million | 10 |
distance threshold | 10 |
working group | 10 |
chronic inflammation | 10 |
standard deviation | 10 |
patients may | 10 |
health zones | 10 |
high mortality | 10 |
test result | 10 |
standard precautions | 10 |
pediatric patient | 10 |
individual patients | 10 |
clostridium botulinum | 10 |
wistar rats | 10 |
endemic disease | 10 |
elementary school | 10 |
becomes infected | 10 |
geographical area | 10 |
severe disease | 10 |
anthracis spores | 10 |
opinion leaders | 10 |
channel efforts | 10 |
tax rate | 10 |
mental health | 10 |
system may | 10 |
recent advances | 10 |
multiple locations | 10 |
suspicious case | 10 |
protective antigen | 10 |
copper phthalocyanine | 10 |
network structure | 10 |
causative agents | 10 |
pregnant women | 10 |
federal bureau | 10 |
chemical terrorism | 10 |
acute radiation | 10 |
life science | 10 |
goblet cell | 10 |
lung injury | 10 |
epidemic spread | 10 |
also found | 10 |
jakob disease | 10 |
complex systems | 10 |
aids transmission | 10 |
healthy agent | 10 |
recent years | 10 |
expected number | 10 |
epidemic disease | 10 |
disease outbreak | 10 |
severe cases | 10 |
simple model | 10 |
emergency management | 10 |
following exposure | 10 |
comparative statics | 10 |
influence role | 10 |
lymphoid aggregates | 10 |
probability density | 10 |
artificial societies | 9 |
infection level | 9 |
sodium bromide | 9 |
syndrome definitions | 9 |
becoming infected | 9 |
currently available | 9 |
entire population | 9 |
cynomolgus monkeys | 9 |
differential equations | 9 |
one channel | 9 |
weapons program | 9 |
antimicrobial agent | 9 |
intestinal villi | 9 |
anthrax attack | 9 |
chronic inflammatory | 9 |
shooter committed | 9 |
weight loss | 9 |
agents must | 9 |
united nations | 9 |
simulation models | 9 |
threat assessment | 9 |
many agents | 9 |
two main | 9 |
antimicrobial therapy | 9 |
clinical cases | 9 |
eid agents | 9 |
distance probability | 9 |
nan doi | 9 |
environmental factors | 9 |
occurring epidemics | 9 |
valley fever | 9 |
alkaline phosphatase | 9 |
rhesus monkeys | 9 |
sierra leone | 9 |
may cause | 9 |
forestomach mucosa | 9 |
oral mucosa | 9 |
based dynamic | 9 |
rat gastric | 9 |
contagion probability | 9 |
massive testing | 9 |
new technologies | 9 |
ionising radiation | 9 |
postal service | 9 |
genetic engineering | 9 |
network position | 9 |
body mucosa | 9 |
social disruption | 9 |
least one | 9 |
mathematical modeling | 9 |
million people | 9 |
health area | 9 |
new method | 9 |
agent server | 9 |
ammonium chloride | 9 |
take place | 9 |
geographic area | 9 |
mass ingress | 9 |
medical care | 9 |
industrial chemicals | 9 |
pandemic influenza | 9 |
light microscopic | 9 |
epidemic models | 9 |
food safety | 9 |
many countries | 9 |
cement composite | 9 |
also shown | 9 |
commercially available | 9 |
enzyme activity | 9 |
prion protein | 9 |
national level | 9 |
exposure prophylaxis | 9 |
health emergencies | 9 |
select agents | 9 |
rift valley | 9 |
game theory | 9 |
care providers | 9 |
decision support | 9 |
must also | 9 |
future directions | 9 |
venezuelan equine | 9 |
normal distribution | 9 |
also possible | 9 |
cell membrane | 9 |
many years | 9 |
enhanced raman | 9 |
drinking water | 9 |
economic models | 9 |
highly effective | 9 |
cement mortar | 9 |
clinical microbiology | 9 |
one person | 9 |
gp clinic | 9 |
hong kong | 9 |
clinical laboratory | 9 |
million deaths | 9 |
moore neighborhood | 9 |
emerging pathogens | 9 |
peak infection | 9 |
gold nanorod | 9 |
random walk | 9 |
microscopic epidemic | 9 |
three different | 9 |
dynamic environments | 9 |
ricin toxin | 9 |
antimicrobial activity | 9 |
mobile agents | 9 |
transgenic mice | 9 |
two agents | 9 |
copula theory | 9 |
social simulation | 9 |
human cases | 9 |
simulation results | 9 |
policy measures | 9 |
new cases | 9 |
identi fi | 9 |
beagle dogs | 9 |
gastric mucosal | 9 |
researchers indicated | 9 |
long time | 9 |
proposed strategy | 9 |
respiratory secretions | 9 |
sverdlovsk anthrax | 9 |
infection starts | 9 |
decentralized groups | 9 |
pulmonary edema | 9 |
based solution | 9 |
may require | 9 |
quantitative detection | 9 |
will need | 9 |
research institute | 9 |
contrast agents | 9 |
different countries | 9 |
bioterrorism risk | 9 |
see ref | 9 |
negative effect | 9 |
threat agent | 9 |
virus infections | 9 |
animal model | 9 |
deliberate use | 8 |
minor salivary | 8 |
induced gastric | 8 |
infected mice | 8 |
center channels | 8 |
disseminated intravascular | 8 |
ionizing radiation | 8 |
vaccine reserve | 8 |
hva thira | 8 |
protease inhibitors | 8 |
filters placed | 8 |
diagnostic tests | 8 |
monitoring methods | 8 |
contact data | 8 |
economic consequences | 8 |
time required | 8 |
intravascular coagulation | 8 |
columnar cells | 8 |
different scenarios | 8 |
linked immunosorbent | 8 |
associated lymphoid | 8 |
rapid ripost | 8 |
peripheral ones | 8 |
epidemiological models | 8 |
years ago | 8 |
local public | 8 |
became ill | 8 |
see chapter | 8 |
fi rst | 8 |
numerical results | 8 |
many cases | 8 |
system must | 8 |
larger radii | 8 |
contact network | 8 |
terrorist attack | 8 |
hepatitis virus | 8 |
system will | 8 |
power law | 8 |
graphical games | 8 |
relatively low | 8 |
numerical simulations | 8 |
expected degree | 8 |
dif fi | 8 |
species differences | 8 |
epidemic outbreaks | 8 |
intensive care | 8 |
known endemic | 8 |
new vaccines | 8 |
former soviet | 8 |
early warning | 8 |
spanish influenza | 8 |
key role | 8 |
decision tree | 8 |
smallpox vaccination | 8 |
civilian biodefense | 8 |
traumatic brain | 8 |
sensitive detection | 8 |
potential risk | 8 |
antral mucosa | 8 |
sewer systems | 8 |
incapacitating agents | 8 |
individual learning | 8 |
two groups | 8 |
initially inside | 8 |
ivc rack | 8 |
immune globulin | 8 |
nmda receptor | 8 |
recent studies | 8 |
submandibular glands | 8 |
stained sections | 8 |
groups composed | 8 |
network formation | 8 |
cell culture | 8 |
healthcare worker | 8 |
better understand | 8 |
disease stages | 8 |
vaccination strategies | 8 |
radiation exposure | 8 |
clinical presentations | 8 |
agent model | 8 |
long periods | 8 |
antimicrobial properties | 8 |
floor nurses | 8 |
blood cultures | 8 |
potential agents | 8 |
cost function | 8 |
sandwich mode | 8 |
rat salivary | 8 |
deliberate outbreak | 8 |
social norms | 8 |
infections created | 8 |
saudi arabia | 8 |
health information | 8 |
health systems | 8 |
low levels | 8 |
first three | 8 |
bt attacks | 8 |
also provides | 8 |
attack using | 8 |
two weeks | 8 |
small world | 8 |
maximum number | 8 |
interactive learning | 8 |
immunocytochemical study | 8 |
stem cells | 8 |
getting infected | 8 |
spatial distribution | 8 |
new agents | 8 |
raman scattering | 8 |
also include | 8 |
intestinal epithelial | 8 |
motivation parameter | 8 |
differential equation | 8 |
potential bioterrorism | 8 |
growth rate | 8 |
microbial corrosion | 8 |
mortar specimens | 8 |
information sharing | 8 |
several days | 8 |
one hand | 8 |
agent reinforcement | 8 |
recognition element | 8 |
individual behavior | 8 |
mtmc hypothesis | 8 |
case fatality | 8 |
police arrived | 8 |
coping strategies | 8 |
agents within | 8 |
medical research | 8 |
initial infected | 8 |
lassa fever | 8 |
state configuration | 8 |
spotted fever | 8 |
bioterrorist agents | 8 |
support system | 8 |
economic growth | 8 |
internal decontamination | 8 |
see sect | 8 |
public value | 8 |
office server | 8 |
inflammatory diseases | 8 |
multiplexed multi | 8 |
ca model | 8 |
world networks | 8 |
developed countries | 8 |
interactions among | 8 |
vector control | 8 |
rational agent | 8 |
immune responses | 8 |
variola virus | 8 |
also occurs | 8 |
systemic disease | 8 |
influence roles | 8 |
supportive therapy | 8 |
inflammatory responses | 8 |
small size | 8 |
psychological impact | 8 |
real life | 8 |
may need | 8 |
positive pressure | 8 |
using agent | 8 |
chemical agent | 8 |
disease dynamics | 8 |
cholinergic crisis | 8 |
cell types | 8 |
medical services | 8 |
false positive | 8 |
researchers concluded | 8 |
acute inflammatory | 8 |
will continue | 8 |
ripost team | 8 |
incubation periods | 8 |
immunodeficiency virus | 8 |
living organisms | 8 |
control measure | 8 |
three categories | 8 |
anthracis spore | 8 |
skin lesions | 8 |
transmission experiments | 8 |
herding behaviour | 8 |
latent period | 8 |
also used | 8 |
volunteer subjects | 8 |
based lateral | 8 |
hiv infection | 8 |
influenza viruses | 8 |
contact precautions | 8 |
epidemic dynamics | 8 |
neuronal degeneration | 8 |
intentional contamination | 8 |
ca models | 8 |
systematic review | 8 |
fundamental value | 7 |
agent becomes | 7 |
potential consequences | 7 |
prp gene | 7 |
two different | 7 |
virus epidemic | 7 |
also important | 7 |
laboratory rodents | 7 |
low cost | 7 |
first cases | 7 |
culture method | 7 |
dimensional model | 7 |
decontamination procedures | 7 |
abdominal pain | 7 |
production facility | 7 |
fi ed | 7 |
include emerging | 7 |
center agents | 7 |
state transition | 7 |
blood vessels | 7 |
human population | 7 |
another example | 7 |
national council | 7 |
will require | 7 |
one unit | 7 |
biological terrorism | 7 |
essential shops | 7 |
pathogen level | 7 |
animal species | 7 |
relatively small | 7 |
emergency departments | 7 |
susceptible agent | 7 |
cumulative productivity | 7 |
microbiological monitoring | 7 |
making process | 7 |
certain extent | 7 |
secretory granules | 7 |
future work | 7 |
zoonotic diseases | 7 |
rodents housed | 7 |
blast injuries | 7 |
cellular processes | 7 |
ebola outbreak | 7 |
forestomach epithelium | 7 |
immediate isolation | 7 |
also produced | 7 |
contagious disease | 7 |
software agent | 7 |
inhibitory effect | 7 |
intestinal inflammation | 7 |
natural infections | 7 |
clinical suspicion | 7 |
epidemic process | 7 |
brain barrier | 7 |
overall infection | 7 |
monitoring program | 7 |
social life | 7 |
spr sensor | 7 |
emergency department | 7 |
rack exhaust | 7 |
excellent antimicrobial | 7 |
like environment | 7 |
outbreak detection | 7 |
stationary solution | 7 |
detection value | 7 |
test results | 7 |
create new | 7 |
security presidential | 7 |
fever viruses | 7 |
hawkes process | 7 |
experimentally induced | 7 |
negative pressure | 7 |
across channels | 7 |
decision loop | 7 |
another agent | 7 |
human infectious | 7 |
inflammatory cytokines | 7 |
empirical data | 7 |
rat incisor | 7 |
antibacterial agent | 7 |
radiation protection | 7 |
uncertain hazards | 7 |
uniformly distributed | 7 |
transmissible spongiform | 7 |
table shows | 7 |
digestive tract | 7 |
solution strategy | 7 |
neumann neighborhood | 7 |
warfare agent | 7 |
mtmc drugs | 7 |
reproduction number | 7 |
bioterrorism agent | 7 |
every time | 7 |
mission results | 7 |
per unit | 7 |
different ways | 7 |
ng ml | 7 |
gastrointestinal mucosa | 7 |
giant component | 7 |
proliferative activity | 7 |
health response | 7 |
like agents | 7 |
intelligent learning | 7 |
respiratory disease | 7 |
dna viruses | 7 |
unique properties | 7 |
blood transfusion | 7 |
toxic chemicals | 7 |
copper oxide | 7 |
positive effect | 7 |
may influence | 7 |
social learning | 7 |
intestinal epithelium | 7 |
hot zone | 7 |
different agents | 7 |
cell surface | 7 |
health professionals | 7 |
closing schools | 7 |
defender decisions | 7 |
distal colon | 7 |
sir models | 7 |
burkholderia pseudomallei | 7 |
data collection | 7 |
problem solving | 7 |
clostridium difficile | 7 |
transmission routes | 7 |
early diagnosis | 7 |
high dose | 7 |
machine learning | 7 |
increased numbers | 7 |
may include | 7 |
lower respiratory | 7 |
empirical work | 7 |
base locations | 7 |
cell focus | 7 |
transmission dynamics | 7 |
mathematical methods | 7 |
patient care | 7 |
early recognition | 7 |
molecular recognition | 7 |
also known | 7 |
social media | 7 |
cryptosporidium parvum | 7 |
certain strains | 7 |
laboratory personnel | 7 |
anthrax outbreak | 7 |
health impact | 7 |
becoming increasingly | 7 |
urban areas | 7 |
fly ash | 7 |
unit clerk | 7 |
shop floor | 7 |
focal brand | 7 |
stock market | 7 |
composed predominantly | 7 |
pathogenic bacteria | 7 |
different species | 7 |
developing countries | 7 |
mathematical theory | 7 |
protective measures | 7 |
human health | 7 |
historical data | 7 |
natural outbreaks | 7 |
magnetic resonance | 7 |
direct patient | 7 |
systems may | 7 |
us billion | 7 |
chest pain | 7 |
new product | 7 |
one needs | 7 |
bacterial cells | 7 |
network effects | 7 |
insurance industry | 7 |
induced changes | 7 |
past decade | 7 |
rocky mountain | 7 |
initial symptoms | 7 |
spinal cord | 7 |
advancing age | 7 |
chikungunya virus | 7 |
bearing zeolite | 7 |
infective agent | 7 |
time detection | 7 |
planar space | 7 |
mucous membranes | 7 |
mouse hepatitis | 7 |
molecular biology | 7 |
st century | 7 |
epidemiology service | 7 |
get infected | 7 |
random graph | 7 |
outbreak scenarios | 7 |
infected state | 7 |
optimal policy | 7 |
marginal distribution | 7 |
communicable diseases | 7 |
lockdown measures | 7 |
agent may | 7 |
rat stomach | 7 |
consider two | 7 |
west african | 7 |
extreme events | 7 |
communicable disease | 7 |
portfolio choice | 7 |
epidemiological data | 7 |
audit fashion | 7 |
histological examination | 7 |
directly related | 7 |
acutely ill | 7 |
microbial induced | 7 |
immunosorbent assay | 7 |
behavioural random | 7 |
social system | 7 |
crypt abscesses | 7 |
within hours | 7 |
bioweapons program | 7 |
adaptive immune | 7 |
stochastic sir | 7 |
general practitioners | 7 |
next section | 7 |
induced corrosion | 7 |
gives rise | 7 |
aum shinrikyo | 7 |
less dense | 7 |
computer science | 7 |
sulphated mucins | 7 |
airborne precautions | 7 |
nucleic acids | 7 |
biological applications | 7 |
high concentrations | 7 |
first week | 7 |
rats given | 7 |
population size | 7 |
risk factors | 7 |
concealed investment | 7 |
disease risk | 7 |
decay rate | 7 |
air sentinels | 7 |
sars outbreak | 7 |
disaster preparedness | 7 |
varying degrees | 7 |
residence time | 7 |
droplet nuclei | 7 |
ileal mucosa | 7 |
infections may | 7 |
aristolochic acid | 7 |
will choose | 7 |
temporal network | 7 |
model without | 7 |
presidential directive | 7 |
proposed model | 7 |
twentieth century | 7 |
interaction patterns | 7 |
ideal supermarket | 7 |
decision trees | 7 |
economic aspects | 7 |
staff physician | 7 |
acute lung | 7 |
utility function | 7 |
larger radius | 7 |
biosafety level | 7 |
airborne transmission | 7 |
close proximity | 7 |
cases reported | 7 |
primary care | 7 |
safety evaluation | 7 |
large bowel | 7 |
will depend | 7 |
agent must | 7 |
agent coordination | 6 |
nitroso compounds | 6 |
sample preparation | 6 |
dangerous pathogens | 6 |
efficient market | 6 |
calcium formate | 6 |
priority agents | 6 |
monitoring biological | 6 |
biological toxins | 6 |
mean cumulative | 6 |
nonlinear optics | 6 |
multiorgan failure | 6 |
laboratory animal | 6 |
concrete added | 6 |
terrorist organizations | 6 |
independent simulations | 6 |
morphometric analysis | 6 |
agents might | 6 |
system based | 6 |
liposomal formulations | 6 |
diarrheal diseases | 6 |
national institutes | 6 |
social influence | 6 |
borne encephalitis | 6 |
connected individuals | 6 |
system elimination | 6 |
molecular methods | 6 |
united kingdom | 6 |
mycobacterium tuberculosis | 6 |
travelling salesman | 6 |
salmonella spp | 6 |
majority vote | 6 |
zno nanoparticles | 6 |
nipah virus | 6 |
open source | 6 |
national preparedness | 6 |
agent channels | 6 |
based analysis | 6 |
sendai virus | 6 |
studies suggest | 6 |
readily available | 6 |
human primate | 6 |
financial crisis | 6 |
agent exposure | 6 |
pandemic virus | 6 |
agents whose | 6 |
agents diseases | 6 |
corona virus | 6 |
disease spreading | 6 |
southeast asia | 6 |
infectious virus | 6 |
mink cell | 6 |
last years | 6 |
particularly important | 6 |
african ebola | 6 |
inflammatory bowel | 6 |
epsilon toxin | 6 |
watch program | 6 |
iron diamine | 6 |
repeated contacts | 6 |
public panic | 6 |
regional lymph | 6 |
using biological | 6 |
large outbreak | 6 |
mathematical model | 6 |
fi cult | 6 |
potential bt | 6 |
dna extraction | 6 |
rights reserved | 6 |
allowed capacity | 6 |
economic losses | 6 |
odd protocol | 6 |
natural epidemics | 6 |
reporting frequency | 6 |
molecular diagnostic | 6 |
cells within | 6 |
bowel mucosa | 6 |
diseases spread | 6 |
cells may | 6 |
crypt cell | 6 |
tail dependence | 6 |
complex networks | 6 |
optimal actions | 6 |
least two | 6 |
pcr detection | 6 |
inhibitory effects | 6 |
defender risk | 6 |
cots software | 6 |
pediatric emergency | 6 |
auto insurance | 6 |
vaccinia virus | 6 |
middle school | 6 |
restriction fragment | 6 |
air pressure | 6 |
provide information | 6 |
secondary transmission | 6 |
may explain | 6 |
bowel disease | 6 |
rodent forestomach | 6 |
clustering coefficient | 6 |
laboratory diagnosis | 6 |
dual use | 6 |
days later | 6 |
system dynamics | 6 |
detailed differentiation | 6 |
will take | 6 |
molecular imaging | 6 |
length polymorphism | 6 |
severe sepsis | 6 |
sulfuric acid | 6 |
bioterrorism attack | 6 |
sharp phase | 6 |
diagnoses include | 6 |
confidence bands | 6 |
generic agent | 6 |
new information | 6 |
thoracic anthrax | 6 |
solution strategies | 6 |
modeling cycle | 6 |
effect towards | 6 |
also observed | 6 |
surface plasmons | 6 |
different perspectives | 6 |
important part | 6 |
picking time | 6 |
large intestinal | 6 |
optimization approach | 6 |
zoonotic disease | 6 |
curves represent | 6 |
transition probability | 6 |
cell lines | 6 |
contact sentinels | 6 |
intelligent agents | 6 |
serological assays | 6 |
gastrointestinal disease | 6 |
virulence factors | 6 |
cell population | 6 |
traumatic injuries | 6 |
rapid response | 6 |
suppresser cytotoxic | 6 |
pseudomembranous colitis | 6 |
effective response | 6 |
silver copper | 6 |
chosen initial | 6 |
care physicians | 6 |
live cells | 6 |
blast wave | 6 |
biologic agents | 6 |
behavioural variables | 6 |
mobile code | 6 |
gold nanorods | 6 |
specific pathogen | 6 |
increased risk | 6 |
term administration | 6 |
ehr databases | 6 |
ascending colon | 6 |
invisible hand | 6 |
particular agent | 6 |
different classes | 6 |
rat colon | 6 |
may actually | 6 |
cell death | 6 |
first days | 6 |
homo economicus | 6 |
mucosa may | 6 |
stress disorder | 6 |
social contact | 6 |
salmonella typhimurium | 6 |
empirical studies | 6 |
market model | 6 |
thyroid gland | 6 |
human infections | 6 |
secondary education | 6 |
natural epidemic | 6 |
tokyo subway | 6 |
pediatric disaster | 6 |
staphylococcal enterotoxin | 6 |
common cause | 6 |
major cause | 6 |
human recombinant | 6 |
imaginary part | 6 |
select agent | 6 |
given time | 6 |
bioterrorist event | 6 |
state i | 6 |
job shop | 6 |
optical properties | 6 |
immunodeficiency syndrome | 6 |
atrophic gastritis | 6 |
exposed individuals | 6 |
death rates | 6 |
differential diagnosis | 6 |
risk reduction | 6 |
nobel prize | 6 |
phthalocyanine compound | 6 |
anthrax toxin | 6 |
three levels | 6 |
mean productivity | 6 |
tissue sections | 6 |
vaccinations performed | 6 |
concrete specimens | 6 |
two distinct | 6 |
growth hormone | 6 |
bacillus subtilis | 6 |
law distribution | 6 |
care facilities | 6 |
high degree | 6 |
emergency medicine | 6 |
stomach mucosa | 6 |
gauze filters | 6 |
class ph | 6 |
first neighbor | 6 |
complementary dna | 6 |
life cycle | 6 |
microbial colonization | 6 |
highly contagious | 6 |
population vs | 6 |
human stomach | 6 |
proposed method | 6 |
physical distancing | 6 |
detection using | 6 |
much smaller | 6 |
potential threat | 6 |
global burden | 6 |
use agent | 6 |
many infectious | 6 |
restaurant salad | 6 |
recent study | 6 |
underlying network | 6 |
brucella spp | 6 |
may reflect | 6 |
disease caused | 6 |
new infections | 6 |
two cases | 6 |
mucous neck | 6 |
positively charged | 6 |
important groups | 6 |
specific disease | 6 |
adenosine receptor | 6 |
species including | 6 |
upper bound | 6 |
aerosol transmission | 6 |
agent servers | 6 |
mice treated | 6 |
target agent | 6 |
castor beans | 6 |
previously unknown | 6 |
human gastrointestinal | 6 |
crosschannel effects | 6 |
sensor using | 6 |
concrete containing | 6 |
parotid gland | 6 |
allegedly began | 6 |
prevented per | 6 |
public good | 6 |
four types | 6 |
cell growth | 6 |
natural history | 6 |
mean number | 6 |
infections prevented | 6 |
linear models | 6 |
mouse antibody | 6 |
tipping points | 6 |
spread mode | 6 |
serious bioweapons | 6 |
cell cultures | 6 |
simulation modeling | 6 |
theoretical model | 6 |
may involve | 6 |
takes place | 6 |
abrupt onset | 6 |
health areas | 6 |
salad bars | 6 |
specialized laboratories | 6 |
mechanical ventilators | 6 |
traumatic stress | 6 |
threat analysis | 6 |
value function | 6 |
phase i | 6 |
results showed | 6 |
endoplasmic reticulum | 6 |
shown efficacy | 6 |
syndrome definition | 6 |
systems used | 6 |
interaction protocols | 6 |
fatality rates | 6 |
glands may | 6 |
rhesus monkey | 6 |
agent moves | 6 |
based methods | 6 |
inhalational exposure | 6 |
th century | 6 |
carbon monoxide | 6 |
labor markets | 6 |
evasion will | 6 |
comparative studies | 6 |
low concentrations | 6 |
ill virus | 6 |
node i | 6 |
anthrax due | 6 |
norwalk agent | 6 |
individual agent | 6 |
audit strategy | 6 |
neck cells | 6 |
health emergency | 6 |
task force | 6 |
isothiazoline cabamate | 6 |
short period | 6 |
heterogeneous contacts | 6 |
shopping list | 6 |
motion model | 6 |
isolated learning | 6 |
chemical synthesis | 6 |
hemorrhagic meningitis | 6 |
total productivity | 6 |
also seen | 6 |
also associated | 6 |
simulation time | 6 |
real data | 6 |
results indicated | 6 |
virus encephalitis | 6 |
will change | 6 |
drugs may | 6 |
channel level | 6 |
cell membranes | 6 |
business cycles | 6 |
various biological | 6 |
low probability | 6 |
majority votes | 6 |
naturally acquired | 6 |
many different | 6 |
parp inhibitors | 6 |
social sciences | 6 |
puerto rico | 6 |
quantitative indicators | 6 |
agents choose | 6 |
healthy students | 6 |
lethal factor | 6 |
use research | 6 |
financial support | 6 |
complete information | 6 |
drug absorption | 6 |
system using | 6 |
botulinum neurotoxin | 6 |
will make | 6 |
histochemical techniques | 6 |
human immunodeficiency | 6 |
natural disaster | 6 |
bass model | 6 |
restriction measures | 6 |
gingival hyperplasia | 6 |
also called | 6 |
oral therapy | 6 |
arterial air | 6 |
see comment | 6 |
exclusion restriction | 6 |
information system | 6 |
cost shaping | 6 |
multiplex detection | 6 |
distribution function | 6 |
anaphylactoid reactions | 6 |
xmpp messages | 6 |
healthcare system | 6 |
public spaces | 6 |
squamous hyperplasia | 6 |
alps model | 6 |
large amounts | 6 |
single stage | 6 |
inflammatory pharmacology | 6 |
cholera outbreak | 6 |
qualitative indicators | 6 |
life sciences | 6 |
glandular hyperplasia | 6 |
biochemical pathways | 6 |
retention rate | 6 |
health measures | 6 |
neuromuscular junction | 6 |
world data | 6 |
first responders | 6 |
comparative study | 6 |
cells also | 6 |
cell numbers | 6 |
parameter space | 6 |
detection time | 6 |
cell wall | 6 |
hemorrhagic manifestations | 6 |
case definition | 6 |
viral diseases | 6 |
starting point | 5 |
metabolic acidosis | 5 |
morphologically similar | 5 |
web appendix | 5 |
tissue culture | 5 |
strain differences | 5 |
surrounding medium | 5 |
dna synthesis | 5 |
selective detection | 5 |
novo synthesis | 5 |
coordination games | 5 |
long latent | 5 |
index case | 5 |
plague meningitis | 5 |
heavy metal | 5 |
optimal action | 5 |
young pediatric | 5 |
will develop | 5 |
mononuclear cells | 5 |
information systems | 5 |
loaded chabasite | 5 |
containing cells | 5 |
inflammatory changes | 5 |
shigella dysenteriae | 5 |
took place | 5 |
corroded concrete | 5 |
like agent | 5 |
disease propagation | 5 |
several months | 5 |
lipid droplets | 5 |
dynamic environment | 5 |
global health | 5 |
vice versa | 5 |
mesenteric lymph | 5 |
giardia muris | 5 |
several ways | 5 |
control strategies | 5 |
food sources | 5 |
may present | 5 |
financial market | 5 |
hospital workers | 5 |
distributed system | 5 |
human infection | 5 |
native americans | 5 |
may extend | 5 |
squamous mucosa | 5 |
viral infections | 5 |
serine protease | 5 |
parotid glands | 5 |
disease definition | 5 |
shoppers may | 5 |
infections per | 5 |
fragment length | 5 |
constantly connected | 5 |
mimic bioterrorism | 5 |
high probability | 5 |
cases occurred | 5 |
urban environment | 5 |
gastric lesions | 5 |
pg ml | 5 |
bacterial bioterrorism | 5 |
two students | 5 |
publicly available | 5 |
burkholderia mallei | 5 |
determine whether | 5 |
two steps | 5 |
tumor cells | 5 |
checkout points | 5 |
market hypothesis | 5 |
bioterrorism incident | 5 |
mission requester | 5 |
alpha particles | 5 |
rotavirus infections | 5 |
computational modeling | 5 |
health security | 5 |
initial resuscitation | 5 |
complex system | 5 |
mechanical properties | 5 |
joe copula | 5 |
unconcealed risky | 5 |
many aspects | 5 |
bowel wall | 5 |
multiagent system | 5 |
aspergillus niger | 5 |
quaternary ammonium | 5 |
simbio virtual | 5 |
emerging diseases | 5 |
help us | 5 |
one infected | 5 |
infected persons | 5 |
army medical | 5 |
agent toxicity | 5 |
aids epidemics | 5 |
specific biological | 5 |
brain tissue | 5 |
mrc ox | 5 |
two categories | 5 |
drug administration | 5 |
information available | 5 |
global public | 5 |
high iron | 5 |
natural reservoir | 5 |
spatial patterns | 5 |
gram stain | 5 |
infect others | 5 |
north america | 5 |
human disease | 5 |
isothermal amplification | 5 |
agents used | 5 |
stylized facts | 5 |
associated fibril | 5 |
different approaches | 5 |
reactive changes | 5 |
software agents | 5 |
nonsteroidal anti | 5 |
including one | 5 |
patient contact | 5 |
based plasmonic | 5 |
computational cost | 5 |
vary widely | 5 |
geneva protocol | 5 |
epidemic curve | 5 |
national security | 5 |
fi nd | 5 |
particle size | 5 |
respiratory syncytial | 5 |
incident occurred | 5 |
offline error | 5 |
specific therapy | 5 |
dynamic systems | 5 |
us military | 5 |
large amount | 5 |
chronic administration | 5 |
economic factors | 5 |
antimicrobial watertight | 5 |
benchmark case | 5 |
different times | 5 |
chronic disease | 5 |
increasing number | 5 |
previously mentioned | 5 |
per year | 5 |
will provide | 5 |
detection sensitivity | 5 |
labelled lectins | 5 |
make use | 5 |
among individuals | 5 |
us army | 5 |
refractive index | 5 |
asset allocation | 5 |
cohort study | 5 |
extended ca | 5 |
monte carlo | 5 |
potential loss | 5 |
ectromelia virus | 5 |
term used | 5 |
different channels | 5 |
highly variable | 5 |
certain degree | 5 |
agent missions | 5 |
good instrument | 5 |
gastric damage | 5 |
younger pediatric | 5 |
also induce | 5 |
second highest | 5 |
infections occur | 5 |
watertight admixture | 5 |
proliferative lesions | 5 |
positive externality | 5 |
food poisoning | 5 |
infectious period | 5 |
emergent disease | 5 |
much like | 5 |
aerosol release | 5 |
next time | 5 |
model validation | 5 |
last case | 5 |
ultrasensitive detection | 5 |
false alarms | 5 |
viable bacterial | 5 |
community outbreak | 5 |
subway system | 5 |
proposed approach | 5 |
policy makers | 5 |
people will | 5 |
also provide | 5 |
clinical findings | 5 |
term treatment | 5 |
case studies | 5 |
quite different | 5 |
pathologies caused | 5 |
event trees | 5 |
system optimum | 5 |
based evolutionary | 5 |
detection limit | 5 |
ultimate goal | 5 |
across agents | 5 |
following treatment | 5 |
cerebrospinal fluid | 5 |
hev rna | 5 |
three control | 5 |
will try | 5 |
highly communicable | 5 |
histochemical study | 5 |
targeting children | 5 |
take care | 5 |
water treatment | 5 |
local community | 5 |
experimental study | 5 |
inflammatory mtmc | 5 |
limited rationality | 5 |
personal communication | 5 |
mucous cell | 5 |
occurring disease | 5 |
life support | 5 |
animals including | 5 |
network interactions | 5 |
based social | 5 |
symptomatic agents | 5 |
close contact | 5 |
distributed random | 5 |
carcinogenicity bioassays | 5 |
capital gains | 5 |
cellular atypia | 5 |
different strategies | 5 |
analysis model | 5 |
adenomatous polyps | 5 |
health officials | 5 |
dimethyl prostaglandin | 5 |
pathological changes | 5 |
less toxic | 5 |
classic clinical | 5 |
diagnostic capacity | 5 |
related inhalational | 5 |
random graphs | 5 |
crypt cells | 5 |
structural changes | 5 |
chronic infections | 5 |
aggregation variables | 5 |
processing times | 5 |
integrating agent | 5 |
symptomatic cases | 5 |
gastric enterochromaffin | 5 |
optimal tax | 5 |
preventable diseases | 5 |
eight models | 5 |
also cause | 5 |
key features | 5 |
high temperature | 5 |
viruses may | 5 |
inflammatory process | 5 |
factors associated | 5 |
cause acute | 5 |
infectious particles | 5 |
disaster planning | 5 |
reduce tax | 5 |
asymptomatic agents | 5 |
agent daemons | 5 |
agents tend | 5 |
metal ions | 5 |
antibody testing | 5 |
syncytial virus | 5 |
allow one | 5 |
one may | 5 |
source code | 5 |
colonic hyperplasia | 5 |
power utility | 5 |
social dilemma | 5 |
specific identification | 5 |
fatal inhalational | 5 |
medical attention | 5 |
lethal dose | 5 |
smoke inhalation | 5 |
acid sequence | 5 |
many ways | 5 |
oral administration | 5 |
biomedical research | 5 |
plasma membrane | 5 |
patients infected | 5 |
participating hosts | 5 |
concrete corrosion | 5 |
vaccination trials | 5 |
years later | 5 |
clinical efficacy | 5 |
treatment regimens | 5 |
weapons programs | 5 |
cells show | 5 |
intranuclear inclusions | 5 |
tritiated thymidine | 5 |
medicinal chemistry | 5 |
based algorithms | 5 |
gastric ulceration | 5 |
influenza vaccination | 5 |
enforcement arrived | 5 |
electrolyte solutions | 5 |
positive results | 5 |
paneth cell | 5 |
worth noting | 5 |
search space | 5 |
advisory committee | 5 |
railsback grimm | 5 |
adverse events | 5 |
decentralized learning | 5 |
community life | 5 |
clostridium perfringens | 5 |
whole blood | 5 |
stochastic dominance | 5 |
human epidermal | 5 |
data sets | 5 |
health surveillance | 5 |
laboratory confirmation | 5 |
epidemiology workbench | 5 |
attack rates | 5 |
aerosol route | 5 |
small fraction | 5 |
environmental detection | 5 |
agar plates | 5 |
clinical use | 5 |
photonic crystals | 5 |
another important | 5 |
without cross | 5 |
expected return | 5 |
sensor systems | 5 |
new world | 5 |
central level | 5 |
math modeling | 5 |
proliferative changes | 5 |
channel choice | 5 |
primary septicemic | 5 |
possible explanation | 5 |
contact attempts | 5 |
bodily fluids | 5 |
floor nurse | 5 |
animal products | 5 |
learning process | 5 |
related features | 5 |
give rise | 5 |
indirect punishment | 5 |
time interval | 5 |
complicated samples | 5 |
agent reaches | 5 |
model based | 5 |
sensitivity analysis | 5 |
mountain spotted | 5 |
clinical data | 5 |
notional data | 5 |
localized surface | 5 |
single dose | 5 |
inflammatory disease | 5 |
will vary | 5 |
host range | 5 |
spontaneous natural | 5 |
mass loss | 5 |
moderate morbidity | 5 |
human mobility | 5 |
much attention | 5 |
assistant secretary | 5 |
large portion | 5 |
expected consequences | 5 |
little attention | 5 |
agent contacts | 5 |
ventilated cage | 5 |
influenza vaccine | 5 |
complex adaptive | 5 |
highly dynamic | 5 |
exponential growth | 5 |
natural foci | 5 |
cdc category | 5 |
civilian populations | 5 |
cancer therapy | 5 |
classification scheme | 5 |
false negative | 5 |
study showed | 5 |
serial dependence | 5 |
ill victims | 5 |
epidemic diseases | 5 |
nitrocellulose membrane | 5 |
findings include | 5 |
susceptible individuals | 5 |
brucella melitensis | 5 |
population will | 5 |
model uses | 5 |
herpes simplex | 5 |
agent decision | 5 |
health preparedness | 5 |
marburg viruses | 5 |
germ warfare | 5 |
urban area | 5 |
vaccination strategy | 5 |
social connections | 5 |
will lead | 5 |
peripheral areas | 5 |
infected population | 5 |
another way | 5 |
histological sections | 5 |
major health | 5 |
persuasive role | 5 |
sentinels exposed | 5 |
mucosal mast | 5 |
often used | 5 |
sars epidemic | 5 |
biodefense programs | 5 |
immune function | 5 |
laboratory workers | 5 |
parameter sets | 5 |
transmission mechanisms | 5 |
intestinal wall | 5 |
system also | 5 |
raise suspicion | 5 |
indirect transmission | 5 |
social restriction | 5 |
staff members | 5 |
many researchers | 5 |
air embolism | 5 |
collision avoidance | 5 |
contaminated food | 5 |
two decades | 5 |
titanium dioxide | 5 |
negative impact | 5 |
intervention development | 5 |
nile fever | 5 |
distance coefficient | 5 |
rickettsia prowazekii | 5 |
surgeon general | 5 |
infected animal | 5 |
secondary infection | 5 |
raman spectroscopy | 5 |
experimental work | 5 |
mucosal immunity | 5 |
agent within | 5 |
clinical diagnosis | 5 |
allows us | 5 |
reverse transcriptase | 5 |
concrete samples | 5 |
tympanic membranes | 5 |
glands lined | 5 |
weaponized anthrax | 5 |
effective holding | 5 |
contaminated clothing | 5 |
years see | 5 |
surface area | 5 |
bioterrorist attacks | 5 |
copper zeolites | 5 |
recombinant epidermal | 5 |
pathogenic microorganisms | 5 |
income effect | 5 |
stage game | 5 |
static optimization | 5 |
acidithiobacillus thiooxidans | 5 |
intentional use | 5 |
small quantities | 5 |
centralised storage | 5 |
scale attacks | 5 |
silver bearing | 5 |
model assumes | 5 |
shortest path | 5 |
reproductive number | 5 |
emerging infections | 5 |
natural transmission | 5 |
even without | 5 |
induced colitis | 5 |
neutral mucosubstances | 5 |
south american | 5 |
macaca mulatta | 5 |
acid sequences | 5 |
signaling pathways | 5 |
mast cell | 5 |
crush syndrome | 5 |
hyperplasia without | 5 |
many viruses | 5 |
laboratory tests | 5 |
dwell time | 5 |
computed tomography | 5 |
discussed earlier | 5 |
offensive biological | 5 |
better understanding | 5 |
long run | 5 |
outcome variables | 5 |
day course | 5 |
rat submandibular | 5 |
methods used | 5 |
spontaneous lesions | 5 |
hospital population | 5 |
operational models | 5 |
mass critical | 5 |
military use | 5 |
digestive system | 5 |
low mortality | 5 |
government agencies | 5 |
pcr assay | 5 |
simple rules | 5 |
ricinus communis | 5 |
social dynamics | 5 |
poisson process | 5 |
past years | 5 |
novichok agents | 5 |
viral encephalitis | 5 |
discrete time | 5 |
risk groups | 5 |
uniform distribution | 5 |
degree distributions | 5 |
may remain | 5 |
scientific knowledge | 5 |
autonomous agents | 5 |
acquired pneumonia | 5 |
maximum possible | 5 |
bacterial agents | 5 |
colony mice | 5 |
planning scenarios | 5 |
internal state | 5 |
clinical specimens | 5 |
gastrointestinal toxicity | 5 |
signi fi | 5 |
changes induced | 5 |
dendritic cells | 5 |
section provides | 5 |
care facility | 5 |
results indicate | 5 |
nan sha | 5 |
various factors | 5 |
three main | 5 |
reservoir host | 5 |
cystic fibrosis | 5 |
disease spreads | 5 |
agent might | 5 |
pcr amplification | 5 |
hospital contact | 5 |
adaptive response | 5 |
pathogen reduction | 5 |
significantly higher | 5 |
human small | 5 |
mass shootings | 5 |
unique vulnerabilities | 5 |
one health | 5 |
several different | 5 |
making decisions | 5 |
laboratory testing | 5 |
toxic substances | 5 |
way communication | 5 |
artificial intelligence | 5 |
clinical syndrome | 5 |
human influenza | 5 |
human body | 5 |
military forces | 5 |
move around | 5 |
inflammatory lesions | 5 |
regression tree | 5 |
organ systems | 5 |
time slot | 5 |
small amount | 5 |
transmission threat | 5 |
incidents occurred | 5 |
network model | 5 |
infection will | 5 |
substitution effect | 5 |
initial phase | 5 |
staphylococcus aureus | 5 |
asymptomatic patients | 5 |
health threats | 5 |
research agenda | 5 |
state space | 5 |
ulcerogenic potential | 5 |
tissue samples | 5 |
based simulations | 5 |
large community | 5 |
infect humans | 5 |
prairie dogs | 5 |
social contagion | 5 |
patient data | 5 |
viral dna | 5 |
acid mucins | 5 |
medical treatment | 5 |
sis endemic | 5 |
social workers | 5 |
horseradish peroxidase | 5 |
will increase | 5 |
dna polymerase | 5 |
clinically apparent | 5 |
caging systems | 5 |
viral rna | 5 |
home measures | 5 |
gastric erosions | 5 |
data used | 5 |
animal studies | 4 |
two ways | 4 |
cd positive | 4 |
laboratory species | 4 |
third highest | 4 |
factor receptor | 4 |
dynamical behavior | 4 |
nuclear weapons | 4 |
stay home | 4 |
high levels | 4 |
highly correlated | 4 |
specific enhancements | 4 |
morphologic changes | 4 |
problem solution | 4 |
current research | 4 |
hind limbs | 4 |
adoption rates | 4 |
adaptive systems | 4 |
disaster response | 4 |
may serve | 4 |
interactive map | 4 |
observation period | 4 |
less common | 4 |
offline sales | 4 |
susceptible persons | 4 |
distributed epidemiology | 4 |
colonic mucosal | 4 |
canonical model | 4 |
one component | 4 |
seek medical | 4 |
odontogenic tumours | 4 |
behavior will | 4 |
antibacterial effect | 4 |
biological system | 4 |
situ hybridization | 4 |
control methods | 4 |
similar results | 4 |
animals may | 4 |
every year | 4 |
long lasting | 4 |
gas phase | 4 |
state will | 4 |
respiratory droplets | 4 |
academic health | 4 |
recent developments | 4 |
complex social | 4 |
algorithm produced | 4 |
effective biological | 4 |
rapidly dividing | 4 |
us postal | 4 |
high incidence | 4 |
rash begins | 4 |
sodium nitrite | 4 |
environment may | 4 |
year period | 4 |
city problem | 4 |
special case | 4 |
dimethyl benzyl | 4 |
colonic glands | 4 |
melanosis coli | 4 |
silica microspheres | 4 |
scale production | 4 |
small cell | 4 |
although inflammatory | 4 |
memory feature | 4 |
staining patterns | 4 |
viral inclusions | 4 |
based amplification | 4 |
school security | 4 |
ring vaccination | 4 |
endothelial cells | 4 |
benchmark problem | 4 |
viral particles | 4 |
random network | 4 |
private value | 4 |
highest risk | 4 |
may change | 4 |
etiologic agent | 4 |
targeted vaccination | 4 |
general population | 4 |
coping decisions | 4 |
particular attention | 4 |
quite common | 4 |
pathogen levels | 4 |
value creation | 4 |
face masks | 4 |
blister agents | 4 |
current version | 4 |
job agents | 4 |
mucin histochemistry | 4 |
heterogeneity among | 4 |
mode mission | 4 |
potential targets | 4 |
using gold | 4 |
changes may | 4 |
combinatorial optimization | 4 |
one way | 4 |
disease among | 4 |
emergency operations | 4 |
human anthrax | 4 |
field approximation | 4 |
microbiological testing | 4 |
viral agent | 4 |
also affect | 4 |
driven agent | 4 |
dataset contained | 4 |
specific immune | 4 |
neck region | 4 |
common source | 4 |
medicine doi | 4 |
experimental transmission | 4 |
task specification | 4 |
large groups | 4 |
mucosal cells | 4 |
vascular permeability | 4 |
astute clinician | 4 |
also influence | 4 |
weibull distribution | 4 |
many factors | 4 |
radiation poisoning | 4 |
infection probability | 4 |
clinical spectrum | 4 |
tipping point | 4 |
strain nb | 4 |
prevent transmission | 4 |
key platform | 4 |
increased cell | 4 |
resistant strains | 4 |
vary across | 4 |
mucosal hyperplasia | 4 |
clinical course | 4 |
microorganism bioterrorism | 4 |
feasibility analysis | 4 |
social stereotypes | 4 |
distributed syndromic | 4 |
primary focus | 4 |
vaccine adsorbed | 4 |
whose base | 4 |
concealed account | 4 |
patients suffering | 4 |
biochemical method | 4 |
three groups | 4 |
methyl phosphonate | 4 |
deliberate efforts | 4 |
world network | 4 |
later stages | 4 |
central regions | 4 |
infectious organism | 4 |
management decisions | 4 |
result neg | 4 |
mediated isothermal | 4 |
infected cells | 4 |
several papers | 4 |
creating implantable | 4 |
classical ca | 4 |
national stockpile | 4 |
cranial nerve | 4 |
illinois emergency | 4 |
vesicant model | 4 |
sensing element | 4 |
field experiment | 4 |
field data | 4 |
south america | 4 |
chemically induced | 4 |
eosin stained | 4 |
also showed | 4 |
widespread use | 4 |
via inhalation | 4 |
negative externalities | 4 |
people become | 4 |
national laboratory | 4 |
two models | 4 |
inflammatory conditions | 4 |
large outbreaks | 4 |
borne diseases | 4 |
inorganic antimicrobial | 4 |
less likely | 4 |
human patients | 4 |
bioterror attack | 4 |
produce intestinal | 4 |
public places | 4 |
bernoulli random | 4 |
cage changes | 4 |
mst dyn | 4 |
food service | 4 |
junctional complexes | 4 |
arg min | 4 |
infection may | 4 |
biological effects | 4 |
one time | 4 |
limiting ridge | 4 |
new insights | 4 |
recognition elements | 4 |
catalog channel | 4 |
agents monitoring | 4 |
shooter incident | 4 |
assessing risk | 4 |
may provide | 4 |
gastrin receptor | 4 |
drug safety | 4 |
article will | 4 |
unit time | 4 |
exposed people | 4 |
airborne infectious | 4 |
anthrax vaccination | 4 |
environmental conditions | 4 |
soft targets | 4 |
transfusion safety | 4 |
agents choosing | 4 |
increased vascular | 4 |
staphylococcal enterotoxins | 4 |
best known | 4 |
protective effects | 4 |
theoretical studies | 4 |
interim guidance | 4 |
social welfare | 4 |
elimination clearly | 4 |
concrete fabricated | 4 |
detecting agents | 4 |
like virus | 4 |
theoretical challenges | 4 |
agents spend | 4 |
easily prepared | 4 |
detecting biological | 4 |
literature search | 4 |
another form | 4 |
lesions induced | 4 |
past two | 4 |
analytical predictions | 4 |
preventive measures | 4 |
three clinical | 4 |
major problem | 4 |
viral loads | 4 |
distribution channel | 4 |
responses due | 4 |
face shield | 4 |
shed light | 4 |
significantly increased | 4 |
vaccination problem | 4 |
cell function | 4 |
pneumonic form | 4 |
human sera | 4 |
tract infections | 4 |
well known | 4 |
long terminal | 4 |
environmental stability | 4 |
salesman problem | 4 |
four groups | 4 |
least four | 4 |
control activities | 4 |
targeted delivery | 4 |
people tend | 4 |
common biochemical | 4 |
strategic national | 4 |
detailed discussion | 4 |
molecular techniques | 4 |
will play | 4 |
lactic acid | 4 |
hantavirus pulmonary | 4 |
mg tss | 4 |
ebola hemorrhagic | 4 |
largely supportive | 4 |
severe respiratory | 4 |
diffusion patterns | 4 |